Beaked and gray whales, dilemma of local mountain lions, wild horses in Coyote Creek, coyotes thrive in San Diego canyons
Various Authors 6:38 p.m., Sept. 24
Anadys Pharmaceuticals, which specializes in developing hepatitis C treatments, announced this morning (Oct. 17) that it will be acquired by the pharmaceutical giant Roche for $230 million, or $3.70 a share -- a premium of almost 260% over Friday's close. So today, Anadys stock leapt 250.96% to $3.65. Its board has approved the deal.